CDC Website CDC Website

To Join the NPIN community or

Home » Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01)

Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01)

The purpose of this FOA is to promote research to investigate the underlying molecular mechanisms of HIV infection-induced immune activation and inflammation in the presence of antiretroviral therapy (ART) agents and drugs of abuse. The ultimate goal is to obtain information for developing therapeutic interventions for attenuating chronic inflammation-associated comorbidities as well as for restoring or improving ART efficacy in HIV-infected drug-abusing populations.

Funding Organization
Locations
National
Fund Location Notes
Eligible Organizations
Number of Awards Given
4-5 grants

Minimum Amount: 

$0.00

Maximum Amount: 

$0.00

Average Amount: 

$0.00

Award Amount: 

$0.00
Award Amount Notes
NIDA intends to fund an estimate of 4 - 5 grant awards, corresponding to a total of $3M for fiscal year 2017. Future year amounts will depend on annual appropriations.
Notes
Letter of Intent Date
10/28/16
Application Due Date
11/18/16
Award Date
8/3/16
Open Ended Date
8/3/16
Project Start Date
8/3/16
Application Contact
Vishnudutt
Purohit
United States
(301) 594-5753
vpurohit@nida.nih.gov
(301) 594-5753
Technical Contact
Mark
Swieter, Ph.D.
mswieter@mail.nih.gov
United States
(301) 435-1389
(301) 435-1389
Fund Duration
The maximum project period is 5 years.
Subjects
Audiences
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in the funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Focus Area

Fund Number: 

RFA-DA-17-013

Fund ID: 

5170

Last Updated: 

8/3/16